Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Copper diapers aim to soothe skin – but trial never started

NCT ID NCT06726707

Disease control Sponsor: Hospital Israelita Albert Einstein Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study planned to test whether diapers containing copper could help treat incontinence-associated dermatitis (a painful skin rash) in elderly adults. Researchers wanted to compare copper diapers with regular ones over 28 days. However, the trial was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
copper-based substance in diapers
What this could lead to
If it had worked, copper diapers might have offered a new way to manage skin irritation from incontinence.
What could go wrong
The trial was withdrawn before enrolling anyone, so no data exists. Copper's benefit for this skin condition is unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ability and capability to participate in the study and follow study procedures as determined by the investigator. * With moderate or more intense urinary (ISI ≥ 3) and/or fecal incontinence (Pescatori et al. (B1, B2, B3, C1, C2, C3); * Current users of absorbing incontinence products. * Diagnosed with incontinence-associated dermatitis GLOBIAD 1A or 2A. Exclusion Criteria: * Incontinence-associated dermatitis GLOBIAD 1B or 2B; * The subject who knows about allergy or a history of an adverse reaction to product ingredients or to any topical preparations or skincare products; * The subject who has an active skin condition or a history of recurrent skin conditions, except IAD, that may affect IAD healing; * The subject who was treated in the previous week with systemic or topical agents (except for IAD) that may affect IAD healing process (e.g., steroids); * Subject with a score \< 10 in Mini Nutritional Assessment - Short Form; * Subjects with diabetes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Incontinence-associated dermatitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Fecal Incontinence irritant dermatitis Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Incontinence-associated dermatitis

More trials for these conditions

Other studies related to the condition(s) this trial covers.